Will Wegovy Give You Energy? What the Trial Data Actually Shows

Fatigue is a recognised side effect of semaglutide, most common in the first few weeks of treatment or after a dose increase, and typically settles as the body adjusts.
Clinical trials recorded energy improvement as a secondary quality-of-life finding in longer-term participants — not a direct pharmacological effect of the medicine itself.
Reduced body weight lowers the strain on the cardiovascular system, joints and lungs, which many people experience as greater stamina and less breathlessness during everyday activity.
Eating less while on treatment means protein intake, hydration and micronutrient adequacy matter more, poor nutrition can make tiredness worse and should be discussed with your prescriber.

Semaglutide does not directly boost energy in the way a stimulant might, but many people report feeling more alert and physically capable as their weight falls. Clinical trial data suggest the fatigue some people notice early in treatment tends to ease, and the longer-term picture is more encouraging. Wegovy is a prescription-only medicine, and whether it suits you is a question a prescriber assesses individually. This page unpacks what the evidence says about energy levels during treatment — and what to do if tiredness is getting in the way.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How energy levels change during Wegovy treatment, and why

What the STEP 1 trial found about fatigue and wellbeing

The landmark STEP 1 trial, published in the New England Journal of Medicine, tracked adults with obesity over 68 weeks on semaglutide 2.4mg. The headline result was an average body-weight reduction of around 15%, but quality-of-life scores also improved significantly by the end of the study. Participants reported better physical functioning, the kind of difference that shows up as climbing stairs without pausing or keeping up with the school run.

Fatigue did appear in the side-effect data, but it was concentrated in the early weeks. It ranked lower than nausea in frequency and, for most participants, faded rather than persisted. The mechanism is worth understanding: semaglutide slows gastric emptying and reduces appetite sharply. When calorie intake drops quickly, the body needs a week or two to recalibrate. That adjustment period is real, but it is not the whole story of the treatment.

The longer-term picture, once weight starts to fall meaningfully, points in the opposite direction. Less body mass to carry, a lighter load on the heart and lungs, and reduced joint pressure all feed back into how energetic daily life feels. If you are wondering whether Wegovy gives you energy, the honest answer is that this is not a direct pharmacological effect of semaglutide, it is the downstream consequence of sustained weight loss, and it is why the trial's quality-of-life scores kept improving across the full 68 weeks.

Why some people feel more tired on Wegovy, especially early on

If you are a few weeks into treatment and feeling sluggish rather than energised, you are not imagining it, and you are not alone. Our prescribers hear this regularly. There are a few overlapping reasons it happens.

The most common is reduced food intake without a compensating shift in what is eaten. Semaglutide suppresses appetite substantially. If the calories that disappear were mostly from refined carbohydrates, blood-sugar rhythms can flatten in a way that feels like a steady low-grade tiredness. Protein becomes proportionally more important, it supports muscle and keeps satiety steady between meals. Dehydration is a related issue: nausea can make it harder to drink enough, and even mild dehydration compounds fatigue.

Dose increases are another trigger. The titration schedule for Wegovy, which runs from a low starting dose upward in roughly monthly steps under prescriber guidance, can bring a short wave of GI symptoms and tiredness each time the dose steps up. This is why the titration exists, to give the body time to adapt rather than overwhelming it. The NHS semaglutide page notes fatigue as a known side effect and advises speaking to your healthcare team if it is persistent.

Separate from semaglutide itself: people who carry a significant amount of weight often have disrupted sleep, from obstructive sleep apnoea, joint discomfort, or simply the metabolic burden of obesity. As weight falls, sleep can improve, but that shift takes time and may not be linear.

The difference between early tiredness and a signal worth flagging

Most tiredness on Wegovy resolves within two to four weeks of a new dose. Persistent exhaustion that does not ease, or fatigue accompanied by dizziness, rapid heartbeat, or significant weakness, is worth reporting to your prescriber rather than waiting out. These could point to inadequate nutrition, dehydration, or (less commonly) another clinical issue that warrants investigation.

The MHRA's guidance on GLP-1 medicines highlights that serious side effects are rare, but patients should report unexpected or severe symptoms promptly. The Yellow Card scheme at yellowcard.mhra.gov.uk allows anyone to report a suspected side effect directly to the regulator.

One practical note: people often feel they should push through fatigue on treatment because weight loss is happening. That instinct is understandable, but rest and adequate nutrition are not in conflict with the treatment working. Strength-based activity, even light resistance work, helps preserve muscle mass during weight loss, and many people find that building more energy on Wegovy comes partly from pairing the treatment with consistent movement and good nutrition, rather than resting on the medication alone. Details of the right approach for you sit with your prescriber, not a general content page.

If you want to read more about people's experiences with tiredness specifically, the page on managing low energy on Wegovy covers practical steps, and our overview of how semaglutide affects energy levels goes deeper into the pharmacology.

What sustained weight loss tends to do to energy over time

By around six months of treatment, the pattern most people describe is materially different from the early weeks. The appetite suppression feels familiar rather than disorienting, the GI side effects have settled, and the physical effects of reduced body weight start to compound. Less load on the cardiovascular system means lower resting heart rate and less breathlessness. Joints under less pressure allow longer, easier movement. Sleep, as noted, often improves.

None of this is guaranteed, individual responses vary, and some people find energy remains variable throughout treatment. But the direction of travel in the trial data is clear: sustained weight loss in people with obesity is associated with improved physical function and self-reported vitality.

Wegovy is one semaglutide-based treatment option. If you are weighing it against other approaches, the page on how Wegovy works covers the broader picture, and our general weight-loss treatment overview explains what regulated private treatment involves. For those curious about how Wegovy compares to other semaglutide formulations, our semaglutide guide covers both the injection and oral options.

If you are thinking about starting treatment, a free consultation with one of our prescribers is the right first step. They review your full clinical picture (not just your BMI) before any prescription is written. You can start your free consultation here.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions